Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000652881 | SCV000774753 | likely benign | Neuropathy, hereditary motor and sensory, type 6B | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Molecular Medicine for Neurodegenerative and Neuromuscular Diseases Unit, |
RCV001644735 | SCV001519310 | likely pathogenic | Spastic ataxia | 2021-07-12 | criteria provided, single submitter | research | |
Mayo Clinic Laboratories, |
RCV001356125 | SCV001714737 | uncertain significance | not provided | 2023-06-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002369756 | SCV002684948 | likely benign | Inborn genetic diseases | 2019-12-28 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001356125 | SCV003916963 | uncertain significance | not provided | 2023-01-01 | criteria provided, single submitter | clinical testing | SLC25A46: PM4:Supporting |
Prevention |
RCV003918083 | SCV004728698 | likely benign | SLC25A46-related disorder | 2022-02-02 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Department of Pathology and Laboratory Medicine, |
RCV001356125 | SCV001551198 | uncertain significance | not provided | no assertion criteria provided | clinical testing |